Cefixime

Cefixime

SCHEMBL24946

C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)C(=NOCC(=O)O)c3csc(N)n3)[C@H]2SC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Cefixime. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 8/20 1.00
APEX1 P27695 3/20 1.00
APAF1 O14727 2/20 1.00
LMNA P02545 2/20 1.00
L3MBTL1 Q9Y468 2/20 1.00
TSHR P16473 1/20 1.00
PLCG1 P19174 1/20 1.00
ABCC2 Q92887 1/20 1.00
SIRT5 Q9NXA8 1/20 1.00
PSMD14 O00487 1/20 0.98
MMP2 P08253 1/20 0.98
MAPT P10636 4/20 0.79
ABCC4 O15439 2/20 0.79
CNR1 P21554 1/20 0.79
CTDSP1 Q9GZU7 1/20 0.79
NR1I2 O75469 5/20 0.64
HTR2C P28335 1/20 0.64
PPARG P37231 2/20 0.61
SLC22A6 Q4U2R8 2/20 0.61
SLC22A8 Q8TCC7 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefixime SCHEMBL3553111 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL4812946 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL17131963 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL16072825 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL9483204 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL12374914 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL3553107 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL4812929 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL9483213 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1
Cefixime SCHEMBL49534 1.00 TDP1 (1.00) TDP1APEX1APAF1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 30895 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637481-B2 Boronic acid derivatives and therapeutic uses thereof QPEX BIOPHARMA, INC. (US) 2026-05-26 US claimed
CN-122079926-A Preparation method of cefixime side chain acid active ester with stable quality 2026-05-26 CN claimed
WO-2026104587-A1 CYCLIC BORONIC ACID ESTERS USEFUL AS ADJUVANTS IN THE TREATMENT OF BACTERIAL INFECTIONS ADJUTEC PHARMA AS (NO) 2026-05-21 WO claimed
CN-115215923-B Macrocyclic broad-spectrum antibiotics 豪夫迈·罗氏有限公司 2026-05-19 CN claimed
EP-4740962-A1 PHARMACEUTICAL COMPOSITION, FORMULATION CONTAINING PHARMACEUTICAL COMPOSITION, KIT CONTAINING PHARMACEUTICAL COMPOSITION, PREPARATION METHOD FOR PHARMACEUTICAL COMPOSITION, AND USE OF PHARMACEUTICAL COMPOSITION Shanghai WD Pharmaceutical Co., Ltd (CN) 2026-05-13 EP claimed
EP-4739326-A2 PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA SNIPR Biome ApS (DK) 2026-05-13 EP claimed
EP-4735619-A1 REACTION MEDIUM AND METHOD FOR DETECTING SHIGA TOXIN-PRODUCING E.COLI AND/OR ENTEROHAEMORRHAGIC E.COLI BIOMERIEUX (FR) 2026-05-06 EP claimed
US-20260115234-A1 PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA SNIPR BIOME APS (DK) 2026-04-30 US claimed
US-20260108619-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2026-04-23 US claimed
EP-4724049-A1 MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF Catalent Ontario Limited (CA) 2026-04-15 EP claimed
EP-0680322-A1 PHARMACEUTICAL FORMULATIONS COMPRISING CLAVULANIC ACID ALONE OR IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS SMITHKLINE BEECHAM PLC (GB) 1995-11-08 EP claimed
US-5464616-A Antibiotic enzyme inhibitors and kits SYNPHAR LABORATORIES, IND. (CA) 1995-11-07 US claimed
EP-0678095-A1 CRYSTALLINE PENICILLIN DERIVATIVE, AND ITS PRODUCTION AND USE TAIHO PHARMACEUTICAL CO., LTD. (JP) 1995-10-25 EP claimed
WO-1995012601-A1 CRYSTALLINE PENICILLIN DERIVATIVE, AND ITS PRODUCTION AND USE TAIHO PHARMACEUTICAL CO., LTD. (JP) 1995-05-11 WO claimed
US-5409917-A Topical treatment of acne with cephalosporins Towsend, Marvin S. (US) 1995-04-25 US claimed
WO-1995000527-A1 FUCOSYLATED GLYCOSIDES AS INHIBITORS OF BACTERIAL ADHERENCE ASTRA AKTIEBOLAG (SE) 1995-01-05 WO claimed
WO-1994016696-A1 PHARMACEUTICAL FORMULATIONS COMPRISING CLAVULANIC ACID ALONE OR IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS SMITHKLINE BEECHAM PLC (GB) 1994-08-04 WO claimed
EP-0568200-A2 Pharmaceutical and foodstuff compositions containing transferrius and antibacteral agents for potentiating host defense activity and the treatment of infections IMMUNO JAPAN INC. (JP) 1993-11-03 EP claimed
EP-0530311-A1 THE USE OF PHENYLPROPANOLAMINE AS A MUCUS SECRETAGOGUE IN THE UPPER AIRWAYS Norwich-Eaton Pharmaceuticals, Inc. (US) 1993-03-10 EP claimed
WO-1991017746-A1 THE USE OF PHENYLPROPANOLAMINE AS A MUCUS SECRETAGOGUE IN THE UPPER AIRWAYS NORWICH EATON PHARMACEUTICALS, INC. (US) 1991-11-28 WO claimed